Edwards Lifesciences Corp (EW)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	597,000	596,800	596,700	596,500	596,300	596,200	596,000	595,900	595,700	595,500	595,400	595,200	595,000	594,900	594,700	594,600	594,400	594,200	594,100	593,900
Total assets	US$ in thousands	9,363,200	9,370,800	9,004,000	8,651,200	8,292,500	8,638,200	8,425,100	8,419,900	8,502,600	8,160,300	7,662,100	7,213,700	7,237,100	6,800,800	6,424,100	6,076,100	6,488,100	5,966,300	5,573,500	5,469,300
Debt-to-assets ratio		0.06	0.06	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.08	0.08	0.08	0.09	0.09	0.10	0.09	0.10	0.11	0.11

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $597,000K ÷ $9,363,200K
= 0.06

The debt-to-assets ratio of Edwards Lifesciences Corp has remained relatively stable over the last eight quarters, ranging between 0.06 and 0.07. This indicates that the company's level of debt in relation to its total assets has remained consistent during this period. With a low debt-to-assets ratio, Edwards Lifesciences Corp appears to have a conservative capital structure, suggesting that it relies more on equity financing rather than debt to fund its operations and investments. This lower ratio may indicate lower financial risk and greater financial stability for the company, as it has a higher proportion of assets financed through equity rather than debt. Overall, the consistent and low debt-to-assets ratio of Edwards Lifesciences Corp reflects a financially sound and stable position in managing its capital structure.